autoimmune disease
Suppression of AID catalytic function to limit selection-based survival of GC B cells could become a novel therapy for the treatment of autoimmune disease.
Suppression of <span class="gene" id="21305519-12-15-18">AID</span> catalytic function to limit selection-based survival of GC B cells could become a novel therapy for the treatment of <span class="disease" id="21305519-12-136-154">autoimmune disease</span>.